Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Peter Enggaard

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|March 7, 2018
[Cannabinoids for neuropathic pain management]Lasse Østergaard Andersen, Thomas Peter Enggaard, Jette Højsted
Ugeskrift for Laeger|February 7, 2008
[Long term effect of spinal cord stimulation in a patient with complex regional pain syndrome and phantom pain syndrome type 1 after amputation]Thomas Peter Enggaard, Christian Scherer, Lone Nikolajsen, et al.
Pain Medicine (Malden, Mass.)|October 30, 2013
Prevalence of neuropathic pain according to the IASP grading system in patients with chronic non-malignant painHenrik Bjarke Vaegter, Per Grunwald Andersen, Marianne Frobøse Madsen, et al.
BMJ Open|January 23, 2024
Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: protocol for a phase II, single-centre, double-blind, randomised, placebo-controlled trial (the PINBOT study)Marc Klee, Trine Hørmann Thomsen, Thomas Peter Enggaard, et al.
European Journal of Pain (London, England)|December 26, 2022
Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatmentKanita Zubcevic, Merete Petersen, Flemming Winther Bach, et al.
Arthritis Research & Therapy|June 19, 2026
Osteoarthritis pain inversely correlates with histidine and glutamine following CSF and serum profilingIsobel K Dunstan, Line J H Rasmussen, Fay Probert, et al.
Journal of Pain Research|May 12, 2021
Socio-Demographics, Pain Characteristics, Quality of Life and Treatment Values Before and After Specialized Interdisciplinary Pain Treatment: Results from the Danish Clinical Pain Registry (PainData)Henrik Bjarke Vaegter, Lars Oxlund Christoffersen, Thomas Peter Enggaard, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|March 7, 2018
[Cannabinoids for neuropathic pain management]Lasse Østergaard Andersen, Thomas Peter Enggaard, Jette Højsted
Ugeskrift for Laeger|February 7, 2008
[Long term effect of spinal cord stimulation in a patient with complex regional pain syndrome and phantom pain syndrome type 1 after amputation]Thomas Peter Enggaard, Christian Scherer, Lone Nikolajsen, et al.
Pain Medicine (Malden, Mass.)|October 30, 2013
Prevalence of neuropathic pain according to the IASP grading system in patients with chronic non-malignant painHenrik Bjarke Vaegter, Per Grunwald Andersen, Marianne Frobøse Madsen, et al.
BMJ Open|January 23, 2024
Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: protocol for a phase II, single-centre, double-blind, randomised, placebo-controlled trial (the PINBOT study)Marc Klee, Trine Hørmann Thomsen, Thomas Peter Enggaard, et al.
European Journal of Pain (London, England)|December 26, 2022
Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatmentKanita Zubcevic, Merete Petersen, Flemming Winther Bach, et al.
Arthritis Research & Therapy|June 19, 2026
Osteoarthritis pain inversely correlates with histidine and glutamine following CSF and serum profilingIsobel K Dunstan, Line J H Rasmussen, Fay Probert, et al.
Journal of Pain Research|May 12, 2021
Socio-Demographics, Pain Characteristics, Quality of Life and Treatment Values Before and After Specialized Interdisciplinary Pain Treatment: Results from the Danish Clinical Pain Registry (PainData)Henrik Bjarke Vaegter, Lars Oxlund Christoffersen, Thomas Peter Enggaard, et al.
Pageof 1